301-251-6638
News & Events
February 5, 2021
Vigene Biosciences Plans Major Expansion in Montgomery County, Adding up to 245 New Jobs Global leader in gene therapy […]
November 3, 2020
Vigene Biosciences announces today another key executive addition. Audrey Chang, Ph.D. is appointed as the VP of QC and Analytical Services.
October 12, 2020
Vigene Biosciences announces today an executive addition. Molly McGlaughlin is appointed as Chief Operation Officer.
October 9, 2020
Vigene has entered a contract manufacturing agreement with Rznomics Inc. for its leading pipeline product, RZ-001. RZ-001 is a gene therapy for advanced hepatocellular carcinoma (HCC).
August 31, 2020
Vigene Biosciences made the 2020 Inc. 5000 list of the fastest-growing private companies in America!
